Evidence map›Paper›PMID 32499443›Full record

ArticleScience (New York, N.Y.)2020

NELL2-mediated lumicrine signaling through OVCH2 is required for male fertility.

Daiji Kiyozumi, Taichi Noda, Ryo Yamaguchi, Tomohiro Tobita, Takafumi Matsumura, Kentaro Shimada, Mayo Kodani, Takashi Kohda, Yoshitaka Fujihara, Manabu Ozawa and 7 more

Open access · greenAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
21.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 147 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Frontiers in oncology · 2026
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Testis expressed 50 is essential for maintaining sperm acrosome integrity during epididymal transit.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 2 countries.

Daiji KiyozumiImmunology Frontier Research Center, Osaka University, Suita, Osaka 5650871, Japan.ORCID 0000-0003-3289-227X
Taichi NodaImmunology Frontier Research Center, Osaka University, Suita, Osaka 5650871, Japan.ORCID 0000-0003-0260-7861
Ryo YamaguchiResearch Institute for Microbial Diseases, Osaka University, Suita, Osaka 5650871, Japan.
Tomohiro TobitaResearch Institute for Microbial Diseases, Osaka University, Suita, Osaka 5650871, Japan.ORCID 0000-0002-2645-1382
Takafumi MatsumuraResearch Institute for Microbial Diseases, Osaka University, Suita, Osaka 5650871, Japan.ORCID 0000-0002-0550-8589
Kentaro ShimadaResearch Institute for Microbial Diseases, Osaka University, Suita, Osaka 5650871, Japan.
Mayo KodaniResearch Institute for Microbial Diseases, Osaka University, Suita, Osaka 5650871, Japan.
Takashi KohdaFaculty of Life and Environmental Sciences, University of Yamanashi, Kofu, Yamanashi 4008510, Japan.ORCID 0000-0002-6856-5601
Yoshitaka FujiharaImmunology Frontier Research Center, Osaka University, Suita, Osaka 5650871, Japan.ORCID 0000-0001-8332-3507
Manabu OzawaThe Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo 1088639, Japan.ORCID 0000-0003-3284-7161
Zhifeng YuCenter for Drug Discovery and Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030, USA.ORCID 0000-0001-7278-8253
Gabriella MiklossyCenter for Drug Discovery and Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030, USA.
Kurt M BohrenCenter for Drug Discovery and Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030, USA.ORCID 0000-0002-3183-4118
Masato HorieDepartment of CNS Research, Otsuka Pharmaceutical, Kawauchi-cho, Tokushima 771-0192, Japan.
Masaru OkabeImmunology Frontier Research Center, Osaka University, Suita, Osaka 5650871, Japan.ORCID 0000-0002-0803-9044
Martin M MatzukCenter for Drug Discovery and Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030, USA. mmatzuk@bcm.edu ikawa@biken.osaka-u.ac.jp.ORCID 0000-0002-1445-8632
Masahito IkawaImmunology Frontier Research Center, Osaka University, Suita, Osaka 5650871, Japan. mmatzuk@bcm.edu ikawa@biken.osaka-u.ac.jp.ORCID 0000-0001-9859-6217
The University of Osaka · JPBaylor College of Medicine · USThe University of Tokyo · JPOtsuka (Japan) · JPUniversity of Yamanashi · JP

Funding

Targeting sperm-specific proteins during meiosis and sperm morphogenesisP01HD087157 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI MATZUK, MARTIN M. · 2017 to 2021
$6.2M
Functional analysis of novel testis-expressed secreted and transmembrane proteinsR01HD088412 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI MARTIN M. MATZUK · 2016 to 2026
$4.5M
NICHD NIH HHS P01 HD087157NICHD NIH HHS R01 HD088412
6 · The paper itself

Abstract

The lumicrine system is a postulated signaling system in which testis-derived (upstream) secreted factors enter the male reproductive tract to regulate epididymal (downstream) pathways required for sperm maturation. Until now, no lumicrine factors have been identified. We demonstrate that a testicular germ-cell-secreted epidermal growth factor-like protein, neural epidermal growth factor-like-like 2 (NELL2), specifically binds to an orphan receptor tyrosine kinase, c-ros oncogene 1 (ROS1), and mediates the differentiation of the initial segment (IS) of the caput epididymis. Male mice in which

Indexed as

FertilityADAM ProteinsAnimalsCell CommunicationEndopeptidasesEpididymisInfertility, MaleMaleMembrane GlycoproteinsMiceMice, KnockoutNerve Tissue ProteinsProto-Oncogene ProteinsReceptor Protein-Tyrosine KinasesSpermatozoaTestisAdam32 protein, mouseAdam3 protein, mouseADAM ProteinsEndopeptidasesMembrane GlycoproteinsNell2 protein, mouseNerve Tissue ProteinsovochymaseProto-Oncogene ProteinsReceptor Protein-Tyrosine KinasesRos1 protein, mouse

Identifiers

PMID32499443
PMCPMC7396227
OpenAlexW3033285506

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.